AI Science Tracker
EN

Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma.

Shanghai University of Medicine and Health Sciences · 27 Feb 2023 · medicine

Discovery

Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: A machine-learning-derived four-lncRNA signature combined with AFP and TNM stage predicted early HCC recurrence and was externally validated; interpretation remains predictive rather than causal. External replication and prospective utility were not established in the reviewed material.

Technology: The study uses a the machine-learning model evaluated in this study for the stated combining a machine-learning derived 4-lncrna signature with afp and tnm stages in predicting early recurrence of hepatocellular carcinoma task.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The study uses a the machine-learning model evaluated in this study for the stated combining a machine-learning derived 4-lncrna signature with afp and tnm stages in predicting early recurrence of hepatocellular carcinoma task.
Test and result
A machine-learning-derived four-lncRNA signature combined with AFP and TNM stage predicted early HCC recurrence and was externally validated; interpretation remains predictive rather than causal.
Limitation / still unknown
External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1186/s12864-023-09194-8

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.